Ignite Creation Date:
2024-05-06 @ 2:14 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04255862
Status:
TERMINATED
Last Update Posted:
2021-08-17
First Post:
2020-02-03
Brief Title:
A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-03
First Submit QC Date:
February 3 2020
Study First Post Date:
2020-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-12
Last Update Post Date:
2021-08-17
Last Update Post Date Type:
ACTUAL